10x Genomics Surges 2.58% as Genomics Innovation Drives Investor Interest
10x Genomics climbs 2.58% as investors eye its cutting‑edge genomic software and upcoming product launches, outperforming a soft sector.
- 10X GENOMICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read